MLICM
VRSK icon

Metropolitan Life Insurance Company (MetLife)’s Verisk Analytics VRSK Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VRSK Stock Details VRSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,848
Closed -$1.38M – 2061
2024
Q1 		$1.38M Sell
5,848
-55
-0.9% -$13.2K 0.06% 272
2023
Q4 		$1.41M Sell
5,903
-97
-2% -$23K 0.07% 258
2023
Q3 		$1.42M Sell
6,000
-310
-5% -$73.1K 0.07% 234
2023
Q2 		$1.43M Sell
6,310
-684
-10% -$144K 0.07% 249
2023
Q1 		$1.34M Sell
6,994
-1,881
-21% -$341K 0.07% 261
2022
Q4 		$1.57M Sell
8,875
-300
-3% -$52.7K 0.07% 268
2022
Q3 		$1.56M Sell
9,175
-166
-2% -$31K 0.07% 263
2022
Q2 		$1.62M Sell
9,341
-432
-4% -$80.6K 0.07% 266
2022
Q1 		$2.1M Sell
9,773
-13,140
-57% -$2.59M 0.07% 245
2021
Q4 		$5.24M Sell
22,913
-429
-2% -$93.6K 0.07% 217
2021
Q3 		$4.67M Sell
23,342
-857
-4% -$166K 0.07% 225
2021
Q2 		$4.23M Sell
24,199
-3,737
-13% -$663K 0.06% 260
2021
Q1 		$4.94M Sell
27,936
-1,607
-5% -$294K 0.07% 212
2020
Q4 		$6.13M Sell
29,543
-1,305
-4% -$254K 0.09% 173
2020
Q3 		$5.72M Sell
30,848
-1,235
-4% -$226K 0.1% 162
2020
Q2 		$5.46M Buy
32,083
+395
+1% +$62.4K 0.1% 170
2020
Q1 		$4.42M Sell
31,688
-448
-1% -$70.2K 0.09% 178
2019
Q4 		$4.8M Sell
32,136
-126
-0.4% -$18.7K 0.08% 219
2019
Q3 		$5.1M Buy
32,262
+2
+0% +$310 0.09% 208
2019
Q2 		$4.72M Buy
32,260
+1,554
+5% +$219K 0.08% 220
2019
Q1 		$4.08M Sell
30,706
-1,200
-4% -$146K 0.07% 221
2018
Q4 		$3.48M Sell
31,906
-186
-0.6% -$21.7K 0.07% 230
2018
Q3 		$3.87M Buy
32,092
+409
+1% +$47.6K 0.07% 246
2018
Q2 		$3.41M Buy
31,683
+954
+3% +$102K 0.06% 282
2018
Q1 		$3.2M Buy
30,729
+102
+0.3% +$10.2K 0.05% 305
2017
Q4 		$2.94M Sell
30,627
-49,456
-62% -$4.48M 0.04% 343
2017
Q3 		$6.66M Sell
80,083
-290
-0.4% -$24K 0.04% 410
2017
Q2 		$6.78M Sell
80,373
-1,915
-2% -$155K 0.05% 396
2017
Q1 		$6.68M Sell
82,288
-1,619
-2% -$133K 0.05% 406
2016
Q4 		$6.81M Sell
83,907
-3,028
-3% -$248K 0.05% 387
2016
Q3 		$7.07M Buy
86,935
+109
+0.1% +$9.02K 0.05% 357
2016
Q2 		$7.04M Sell
86,826
-1,939
-2% -$152K 0.05% 351
2016
Q1 		$7.09M Sell
88,765
-1,822
-2% -$133K 0.05% 338
2015
Q4 		$6.96M Buy
90,587
+78,253
+634% +$5.94M 0.05% 335
2015
Q3 		$912K Hold
12,334
– – 0.01% 1239
2015
Q2 		$897K Buy
12,334
+607
+5% +$44.6K 0.01% 1359
2015
Q1 		$837K Hold
11,727
– – 0.01% 1301
2014
Q4 		$751K Buy
11,727
+312
+3% +$19.4K 0.01% 1505
2014
Q3 		$695K Sell
11,415
-86
-0.7% -$5.37K 0.01% 1501
2014
Q2 		$690K Buy
11,501
+1,089
+10% +$65.1K ﹤0.01% 1607
2014
Q1 		$624K Hold
10,412
– – ﹤0.01% 1652
2013
Q4 		$684K Hold
10,412
– – ﹤0.01% 1594
2013
Q3 		$676K Sell
10,412
-140
-1% -$8.83K 0.01% 1549
2013
Q2 		$630K Buy
+10,552
New +$630K 0.01% 1541

Other funds holding VRSK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s VRSK Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Verisk Analytics (VRSK) in Q2 2024, closing a stake of 5,848 shares — an estimated $1.38M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VRSK in Q2 2013 and held it in 44 quarters. The position peaked at $7.09M in Q1 2016. 948 funds tracked by Wall St. Rank hold VRSK as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Verisk Analytics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,848 Verisk Analytics shares in Q2 2024, an estimated $1.38M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Verisk Analytics in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Verisk Analytics position peaked at $7.09M in Q1 2016.
  • 948 funds tracked by Wall St. Rank held Verisk Analytics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.